Cargando…
Urinary Excretion of N(1)-Methylnicotinamide, as a Biomarker of Niacin Status, and Mortality in Renal Transplant Recipients
Renal transplant recipients (RTR) commonly suffer from vitamin B(6) deficiency and its functional consequences add to an association with poor long-term outcome. It is unknown whether niacin status is affected in RTR and, if so, whether this affects clinical outcomes, as vitamin B(6) is a cofactor i...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912198/ https://www.ncbi.nlm.nih.gov/pubmed/31726722 http://dx.doi.org/10.3390/jcm8111948 |
Sumario: | Renal transplant recipients (RTR) commonly suffer from vitamin B(6) deficiency and its functional consequences add to an association with poor long-term outcome. It is unknown whether niacin status is affected in RTR and, if so, whether this affects clinical outcomes, as vitamin B(6) is a cofactor in nicotinamide biosynthesis. We compared 24-h urinary excretion of N(1)-methylnicotinamide (N(1)-MN) as a biomarker of niacin status in RTR with that in healthy controls, in relation to dietary intake of tryptophan and niacin as well as vitamin B(6) status, and investigated whether niacin status is associated with the risk of premature all-cause mortality in RTR. In a prospective cohort of 660 stable RTR with a median follow-up of 5.4 (4.7–6.1) years and 275 healthy kidney donors, 24-h urinary excretion of N(1)-MN was measured with liquid chromatography-tandem mass spectrometry LC-MS/MS. Dietary intake was assessed by food frequency questionnaires. Prospective associations of N(1)-MN excretion with mortality were investigated by Cox regression analyses. Median N(1)-MN excretion was 22.0 (15.8–31.8) μmol/day in RTR, compared to 41.1 (31.6–57.2) μmol/day in healthy kidney donors (p < 0.001). This difference was independent of dietary intake of tryptophan (1059 ± 271 and 1089 ± 308 mg/day; p = 0.19), niacin (17.9 ± 5.2 and 19.2 ± 6.2 mg/day; p < 0.001), plasma vitamin B(6) (29.0 (17.5–49.5), and 42.0 (29.8–60.3) nmol/L; p < 0.001), respectively. N(1)-MN excretion was inversely associated with the risk of all-cause mortality in RTR (HR 0.57; 95% CI 0.45–0.71; p < 0.001), independent of potential confounders. RTR excrete less N(1)-MN in 24-h urine than healthy controls, and our data suggest that this difference cannot be attributed to lower dietary intake of tryptophan and niacin, nor vitamin B(6) status. Importantly, lower 24-h urinary excretion of N(1)-MN is independently associated with a higher risk of premature all-cause mortality in RTR. |
---|